These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 21105758

  • 1. Gender and hypertension management: a sub-analysis of the I-inSYST survey.
    Van der Niepen P, Verbeelen D.
    Blood Press; 2011 Apr; 20(2):69-76. PubMed ID: 21105758
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG, Yao XY, Tao QM, Zheng P, Chen JZ, Zhu JH, Zhang FR, Zheng LR, Zhao LL.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [Abstract] [Full Text] [Related]

  • 4. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004.
    Gu Q, Burt VL, Paulose-Ram R, Dillon CF.
    Am J Hypertens; 2008 Jul; 21(7):789-98. PubMed ID: 18451806
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antihypertensive drug therapy and blood pressure control in men and women: an international perspective.
    Thoenes M, Neuberger HR, Volpe M, Khan BV, Kirch W, Böhm M.
    J Hum Hypertens; 2010 May; 24(5):336-44. PubMed ID: 19798089
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA.
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Physicians' gender is associated with risk factor control in patients on antihypertensive and lipid lowering treatment.
    Journath G, Hellénius ML, Carlsson AC, Wändell PE, Nilsson PM, Hyper-Q and Eko Study Groups, Sweden.
    Blood Press; 2010 Aug; 19(4):240-8. PubMed ID: 20446878
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Institutional hypertension control in Malaysia: a multicenter study focusing on gender and cardiovascular risk factor profile difference.
    Oteh M, Azarisman SM, Azreen SA, Jamaluddin AR, Aszrin A, Ting CK, Shaiful Bahri I.
    Hypertens Res; 2011 Mar; 34(3):319-24. PubMed ID: 21150917
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event.
    Dallongevillle J, De Bacquer D, Heidrich J, De Backer G, Prugger C, Kotseva K, Montaye M, Amouyel P, EUROASPIRE Study Group.
    Heart; 2010 Nov; 96(21):1744-9. PubMed ID: 20956490
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M, Noberasco G, Re M, Filippi A, Gallina AM, Weiss U, Cannavò R, Ravera G, Cricelli C, Deferrari G.
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.